Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Humphreys

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
BJU International|November 4, 2010
Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matchingAhmed Magheli, Mark L Gonzalgo, Li-Ming Su, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 18, 2011
Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA eraCorinne E Joshu, Alison M Mondul, Andy Menke, et al.
The Journal of Urology|August 12, 2005
Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral centerStephen J Freedland, Kelly A Grubb, Sindy K Yiu, et al.
BJU International|July 2, 2016
Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary eraJeffrey J Tosoian, Meera Chappidi, Zhaoyong Feng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2015
Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN)V Launay-Vacher, M Aapro, G De Castro, et al.
Cancer Biomarkers : Section a of Disease Markers|September 26, 2015
Evaluation of two mitochondrial DNA biomarkers for prostate cancer detectionSamantha Maragh, Robert W Veltri, Steven P Lund, et al.
Urology|April 5, 2008
Effect of DNA methylation on identification of aggressive prostate cancerJoshi J Alumkal, Zhe Zhang, Elizabeth B Humphreys, et al.
BJU International|July 28, 2012
An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011John B Eifler, Zhaoyang Feng, Brian M Lin, et al.
BJU International|April 16, 2014
Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk featureFarzana A Faisal, Debasish Sundi, Phillip M Pierorazio, et al.
European Urology|April 30, 2015
Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk MenAshley E Ross, Kasra Yousefi, Elai Davicioni, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
BJU International|November 4, 2010
Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matchingAhmed Magheli, Mark L Gonzalgo, Li-Ming Su, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 18, 2011
Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA eraCorinne E Joshu, Alison M Mondul, Andy Menke, et al.
The Journal of Urology|August 12, 2005
Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral centerStephen J Freedland, Kelly A Grubb, Sindy K Yiu, et al.
BJU International|July 2, 2016
Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary eraJeffrey J Tosoian, Meera Chappidi, Zhaoyong Feng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2015
Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN)V Launay-Vacher, M Aapro, G De Castro, et al.
Cancer Biomarkers : Section a of Disease Markers|September 26, 2015
Evaluation of two mitochondrial DNA biomarkers for prostate cancer detectionSamantha Maragh, Robert W Veltri, Steven P Lund, et al.
Urology|April 5, 2008
Effect of DNA methylation on identification of aggressive prostate cancerJoshi J Alumkal, Zhe Zhang, Elizabeth B Humphreys, et al.
BJU International|July 28, 2012
An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011John B Eifler, Zhaoyang Feng, Brian M Lin, et al.
BJU International|April 16, 2014
Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk featureFarzana A Faisal, Debasish Sundi, Phillip M Pierorazio, et al.
European Urology|April 30, 2015
Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk MenAshley E Ross, Kasra Yousefi, Elai Davicioni, et al.
Pageof 6